Callan Family Office’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Sell
12,845
-826
-6% -$143K 0.04% 366
2026
Q1
$2.31M Sell
13,671
-1,612
-11% -$309K 0.05% 315
2025
Q4
$2.87M Buy
15,283
+1,343
+10% +$253K 0.06% 275
2025
Q3
$2.86M Sell
13,940
-791
-5% -$169K 0.09% 222
2025
Q2
$3.28M Buy
14,731
+10,497
+248% +$2.26M 0.1% 210
2025
Q1
$870K Sell
4,234
-3,925
-48% -$782K 0.07% 237
2024
Q4
$1.49M Buy
+8,159
New +$1.72M 0.09% 183

Other funds holding CTAS

Callan Family Office's CTAS Position: Q2 2026 in Review

Callan Family Office reduced its Cintas (CTAS) stake by 6% in Q2 2026, selling an estimated $143K and leaving 12,845 shares worth $2.18M. The position accounts for 0.04% of the portfolio, ranked #366.

Callan Family Office first reported a position in CTAS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.28M in Q2 2025. 1,432 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Callan Family Office held 12,845 shares of Cintas worth $2.18M as of Q2 2026.
  • Callan Family Office sold 826 Cintas shares in Q2 2026, an estimated $143K.
  • Cintas made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #366 holding.
  • Callan Family Office first reported a position in Cintas in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Cintas position peaked at $3.28M in Q2 2025.
  • 1,432 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.